These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Specific prostatic antigen: usefulness in clinical practice]. Isa Kroon WA; Sánchez de la Muela PL; Berian Polo JM Med Clin (Barc); 1992 Mar; 98(9):345-7. PubMed ID: 1374824 [No Abstract] [Full Text] [Related]
7. Correspondence re: J. B. de Kok et al., DD3, A very sensitive and specific marker to detect prostate tumors. Cancer Res., 62: 2695-2698, 2002. Gandini O; Santulli M; Cardillo MR; Stigliano A; Toscano V Cancer Res; 2003 Aug; 63(15):4747; author reply 4748-9. PubMed ID: 12907658 [No Abstract] [Full Text] [Related]
8. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers]. Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006 [TBL] [Abstract][Full Text] [Related]
9. [Prostate-specific antigen as a prostatic tumor marker. Analysis of results in 206 patients]. RodrÃguez Duarte C Arch Esp Urol; 1991; 44(6):697-700. PubMed ID: 1722962 [TBL] [Abstract][Full Text] [Related]
10. [Isoenzymes of creatine kinase and prostate-specific antigen in the monitoring of prostatic carcinoma]. Scarazatti E; Lino S; Martinoli F; Borroni A Boll Soc Ital Biol Sper; 1990 Jun; 66(6):581-5. PubMed ID: 1701647 [TBL] [Abstract][Full Text] [Related]
11. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate]. Morote Robles J; de Torres Mateos JA Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148 [TBL] [Abstract][Full Text] [Related]
12. Measurement of prostate-specific antigen as a screening test for prostate cancer. N Engl J Med; 1991 Sep; 325(13):963-5. PubMed ID: 1715514 [No Abstract] [Full Text] [Related]
13. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer. Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759 [TBL] [Abstract][Full Text] [Related]
14. [Prostate-specific antigen (PSA) is a valuable marker--if correctly used]. Ekman P Lakartidningen; 1991 Jun; 88(24):2207-8. PubMed ID: 1711643 [No Abstract] [Full Text] [Related]
15. New test detects early prostate cancer. Health News; 2005 Sep; 11(9):9. PubMed ID: 16208809 [No Abstract] [Full Text] [Related]
16. The biochemical monitoring of prostate cancer. Yorkshire Regional Urological Cancer Research Group. Cooper EH; Armitage TG Prog Clin Biol Res; 1990; 357():23-7. PubMed ID: 1699238 [No Abstract] [Full Text] [Related]
17. [The specific prostatic antigen: an element of diagnostic conflict?]. Morote Robles J Med Clin (Barc); 1992 Apr; 98(15):598. PubMed ID: 1376383 [No Abstract] [Full Text] [Related]
18. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein]. Yoshiki T; Okada K; Oishi K; Yoshida O Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559 [TBL] [Abstract][Full Text] [Related]
19. Study shows PSA better than DRE in screening for prostate cancer. Oncology (Williston Park); 1991 Nov; 5(11):36. PubMed ID: 1722420 [No Abstract] [Full Text] [Related]